XIdentification of liver cancer progenitors whose malignant progression depends on autocrine IL-6 signaling

Cell

Volumn 155, Issue 2, 2013, Pages 384-

  He, Guobin ^a   Dhar, Debanjan ^a   Nakagawa, Hayato ^a,h   Font Burgada, Joan ^a   Ogata, Hisanobu ^a,i   Jiang, Yuhong ^a   Shalapour, Shabnam ^a   Seki, Ekihiro ^b   Yost, Shawn E ^a,d   Jepsen, Kristen ^d   Frazer, Kelly A ^a,d,e   Harismendy, Olivier ^a,d,e   Hatziapostolou, Maria ^f   Iliopoulos, Dimitrios ^f   Suetsugu, Atsushi ^c,g   Hoffman, Robert M ^c,g   Tateishi, Ryosuke ^h   Koike, Kazuhiko ^h   Karin, Michael ^a,e  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^c UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^d UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^e UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g ANTICANCER INC   (United States)

^h UNIVERSITY OF TOKYO   (Japan)

ⁱ KYUSHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGENASE; DIETHYLNITROSAMINE; INTERLEUKIN 6;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOCRINE EFFECT; CANCER CELL; CANCER GROWTH; CANCER STEM CELL; CELL ISOLATION; CELL PROLIFERATION; CELL TRANSPLANTATION; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HEPATOCELLULAR CARCINOMA PROGENITOR CELL; IN VIVO STUDY; INFLAMMATORY CELL; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; MALE; MOUSE; NONHUMAN; PARACRINE SIGNALING; PRIORITY JOURNAL; TRANSCRIPTOMICS; UPREGULATION;

EID: 84885671431     PISSN: 00928674     EISSN: 10974172     Source Type: Journal    
DOI: 10.1016/j.cell.2013.09.031     Document Type: Article

References (59)

1. P. Bannasch Sequential cellular changes during chemical carcinogenesis J. Cancer Res. Clin. Oncol. 108 1984 11 22
2. F. Bladt, D. Riethmacher, S. Isenmann, A. Aguzzi, and C. Birchmeier Essential role for the c-met receptor in the migration of myogenic precursor cells into the limb bud Nature 376 1995 768 771
3. J. Deviere, J. Content, C. Denys, P. Vandenbussche, L. Schandene, J. Wybran, and E. Dupont High interleukin-6 serum levels and increased production by leucocytes in alcoholic liver cirrhosis. Correlation with IgA serum levels and lymphokines production Clin. Exp. Immunol. 77 1989 221 225
4. C. Dorrell, L. Erker, J. Schug, J.L. Kopp, P.S. Canaday, A.J. Fox, O. Smirnova, A.W. Duncan, M.J. Finegold, and M. Sander Prospective isolation of a bipotential clonogenic liver progenitor cell in adult mice Genes Dev. 25 2011 1193 1203
5. A.W. Duncan, C. Dorrell, and M. Grompe Stem cells and liver regeneration Gastroenterology 137 2009 466 481
6. R. Eferl, R. Ricci, L. Kenner, R. Zenz, J.P. David, M. Rath, and E.F. Wagner Liver tumor development. c-Jun antagonizes the proapoptotic activity of p53 Cell 112 2003 181 192
7. H.B. El-Serag Hepatocellular carcinoma N. Engl. J. Med. 365 2011 1118 1127
8. S. Grivennikov, and M. Karin Autocrine IL-6 signaling: a key event in tumorigenesis? Cancer Cell 13 2008 7 9
9. C. Guichard, G. Amaddeo, S. Imbeaud, Y. Ladeiro, L. Pelletier, I.B. Maad, J. Calderaro, P. Bioulac-Sage, M. Letexier, and F. Degos Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinoma Nat. Genet. 44 2012 694 698
10. D. Guo, T. Fu, J.A. Nelson, R.A. Superina, and H.E. Soriano Liver repopulation after cell transplantation in mice treated with retrorsine and carbon tetrachloride Transplantation 73 2002 1818 1824
11. X. Guo, L. Xiong, T. Sun, R. Peng, L. Zou, H. Zhu, J. Zhang, H. Li, and J. Zhao Expression features of SOX9 associate with tumor progression and poor prognosis of hepatocellular carcinoma Diagn. Pathol. 7 2012 44
12. D. Haridass, Q. Yuan, P.D. Becker, T. Cantz, M. Iken, M. Rothe, N. Narain, M. Bock, M. Nörder, and N. Legrand Repopulation efficiencies of adult hepatocytes, fetal liver progenitor cells, and embryonic stem cell-derived hepatic cells in albumin-promoter-enhancer urokinase-type plasminogen activator mice Am. J. Pathol. 175 2009 1483 1492
13. M. Hatziapostolou, C. Polytarchou, E. Aggelidou, A. Drakaki, G.A. Poultsides, S.A. Jaeger, H. Ogata, M. Karin, K. Struhl, M. Hadzopoulou-Cladaras, and D. Iliopoulos An HNF4α-miRNA inflammatory feedback circuit regulates hepatocellular oncogenesis Cell 147 2011 1233 1247
14. G. He, G.Y. Yu, V. Temkin, H. Ogata, C. Kuntzen, T. Sakurai, W. Sieghart, M. Peck-Radosavljevic, H.L. Leffert, and M. Karin Hepatocyte IKKbeta/NF-kappaB inhibits tumor promotion and progression by preventing oxidative stress-driven STAT3 activation Cancer Cell 17 2010 286 297
15. R.H. Hruban, A. Maitra, S.E. Kern, and M. Goggins Precursors to pancreatic cancer Gastroenterol. Clin. North Am. 36 2007 831 849 vi
16. P. Hytiroglou, Y.N. Park, G. Krinsky, and N.D. Theise Hepatic precancerous lesions and small hepatocellular carcinoma Gastroenterol. Clin. North Am. 36 2007 867 887 vii
17. N. Ichinohe, J. Kon, K. Sasaki, Y. Nakamura, H. Ooe, N. Tanimizu, and T. Mitaka Growth ability and repopulation efficiency of transplanted hepatic stem cells, progenitor cells, and mature hepatocytes in retrorsine-treated rat livers Cell Transplant. 21 2012 11 22
18. D. Iliopoulos, H.A. Hirsch, and K. Struhl An epigenetic switch involving NF-kappaB, Lin28, Let-7 MicroRNA, and IL6 links inflammation to cell transformation Cell 139 2009 693 706
19. S. Inokuchi, T. Aoyama, K. Miura, C.H. Osterreicher, Y. Kodama, K. Miyai, S. Akira, D.A. Brenner, and E. Seki Disruption of TAK1 in hepatocytes causes hepatic injury, inflammation, fibrosis, and carcinogenesis Proc. Natl. Acad. Sci. USA 107 2010 844 849
20. J. Ji, J. Shi, A. Budhu, Z. Yu, M. Forgues, S. Roessler, S. Ambs, Y. Chen, P.S. Meltzer, and C.M. Croce MicroRNA expression, survival, and response to interferon in liver cancer N. Engl. J. Med. 361 2009 1437 1447
21. S. Kakumu, T. Shinagawa, T. Ishikawa, K. Yoshioka, T. Wakita, and N. Ida Interleukin 6 production by peripheral blood mononuclear cells in patients with chronic hepatitis B virus infection and primary biliary cirrhosis Gastroenterol. Jpn. 28 1993 18 24
22. J.S. Kang, H. Wanibuchi, K. Morimura, F.J. Gonzalez, and S. Fukushima Role of CYP2E1 in diethylnitrosamine-induced hepatocarcinogenesis in vivo Cancer Res. 67 2007 11141 11146
23. E. Laconi, R. Oren, D.K. Mukhopadhyay, E. Hurston, S. Laconi, P. Pani, M.D. Dabeva, and D.A. Shafritz Long-term, near-total liver replacement by transplantation of isolated hepatocytes in rats treated with retrorsine Am. J. Pathol. 153 1998 319 329
24. S. Maeda, H. Kamata, J.L. Luo, H. Leffert, and M. Karin IKKbeta couples hepatocyte death to cytokine-driven compensatory proliferation that promotes chemical hepatocarcinogenesis Cell 121 2005 977 990
25. J.U. Marquardt, and S.S. Thorgeirsson Stem cells in hepatocarcinogenesis: evidence from genomic data Semin. Liver Dis. 30 2010 26 34
26. K. Meyer, J.S. Lee, P.A. Dyck, W.Q. Cao, M.S. Rao, S.S. Thorgeirsson, and J.K. Reddy Molecular profiling of hepatocellular carcinomas developing spontaneously in acyl-CoA oxidase deficient mice: comparison with liver tumors induced in wild-type mice by a peroxisome proliferator and a genotoxic carcinogen Carcinogenesis 24 2003 975 984
27. S. Mikhail, and A.R. He Liver cancer stem cells Int. J. Hepatol. 2011 2011 486954
28. W.E. Naugler, T. Sakurai, S. Kim, S. Maeda, K. Kim, A.M. Elsharkawy, and M. Karin Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production Science 317 2007 121 124
29. L.V. Nguyen, R. Vanner, P. Dirks, and C.J. Eaves Cancer stem cells: an evolving concept Nat. Rev. Cancer 12 2012 133 143
30. P.C. Nowell The clonal evolution of tumor cell populations Science 194 1976 23 28
31. E.J. Park, J.H. Lee, G.Y. Yu, G. He, S.R. Ali, R.G. Holzer, C.H. Osterreicher, H. Takahashi, and M. Karin Dietary and genetic obesity promote liver inflammation and tumorigenesis by enhancing IL-6 and TNF expression Cell 140 2010 197 208
32. H.C. Pitot Altered hepatic foci: their role in murine hepatocarcinogenesis Annu. Rev. Pharmacol. Toxicol. 30 1990 465 500
33. C. Porta, M. De Amici, S. Quaglini, C. Paglino, F. Tagliani, A. Boncimino, R. Moratti, and G.R. Corazza Circulating interleukin-6 as a tumor marker for hepatocellular carcinoma Ann. Oncol. 19 2008 353 358
34. A. Quintana, M. Erta, B. Ferrer, G. Comes, M. Giralt, and J. Hidalgo Astrocyte-specific deficiency of interleukin-6 and its receptor reveal specific roles in survival, body weight and behavior Brain Behav. Immun. 27 2013 162 173
35. H.M. Rabes Development and growth of early preneoplastic lesions induced in the liver by chemical carcinogens J. Cancer Res. Clin. Oncol. 106 1983 85 92
36. J.A. Rhim, E.P. Sandgren, J.L. Degen, R.D. Palmiter, and R.L. Brinster Replacement of diseased mouse liver by hepatic cell transplantation Science 263 1994 1149 1152
37. P. Sansone, G. Storci, S. Tavolari, T. Guarnieri, C. Giovannini, M. Taffurelli, C. Ceccarelli, D. Santini, P. Paterini, and K.B. Marcu IL-6 triggers malignant features in mammospheres from human ductal breast carcinoma and normal mammary gland J. Clin. Invest. 117 2007 3988 4002
38. S. Seki, H. Sakaguchi, T. Kitada, A. Tamori, T. Takeda, N. Kawada, D. Habu, K. Nakatani, S. Nishiguchi, and S. Shiomi Outcomes of dysplastic nodules in human cirrhotic liver: a clinicopathological study Clin. Cancer Res. 6 2000 3469 3473
39. S. Sell, and H.L. Leffert Liver cancer stem cells J. Clin. Oncol. 26 2008 2800 2805
40. S. Shin, G. Walton, R. Aoki, K. Brondell, J. Schug, A. Fox, O. Smirnova, C. Dorrell, L. Erker, and A.S. Chu Foxl1-Cre-marked adult hepatic progenitors have clonogenic and bilineage differentiation potential Genes Dev. 25 2011 1185 1192
41. M. Soresi, L. Giannitrapani, F. D'Antona, A.M. Florena, E. La Spada, A. Terranova, M. Cervello, N. D'Alessandro, and G. Montalto Interleukin-6 and its soluble receptor in patients with liver cirrhosis and hepatocellular carcinoma World J. Gastroenterol. 12 2006 2563 2568
42. Y. Su, R. Kanamoto, D.A. Miller, H. Ogawa, and H.C. Pitot Regulation of the expression of the serine dehydratase gene in the kidney and liver of the rat Biochem. Biophys. Res. Commun. 170 1990 892 899
43. Q. Su, A. Benner, W.J. Hofmann, G. Otto, R. Pichlmayr, and P. Bannasch Human hepatic preneoplasia: phenotypes and proliferation kinetics of foci and nodules of altered hepatocytes and their relationship to liver cell dysplasia Virchows Arch. 431 1997 391 406
44. T. Takayama, M. Makuuchi, S. Hirohashi, M. Sakamoto, N. Okazaki, K. Takayasu, T. Kosuge, Y. Motoo, S. Yamazaki, and H. Hasegawa Malignant transformation of adenomatous hyperplasia to hepatocellular carcinoma Lancet 336 1990 1150 1153
45. B. Terris, C. Cavard, and C. Perret EpCAM, a new marker for cancer stem cells in hepatocellular carcinoma J. Hepatol. 52 2010 280 281
46. M. Tsutsumi, J.M. Lasker, M. Shimizu, A.S. Rosman, and C.S. Lieber The intralobular distribution of ethanol-inducible P450IIE1 in rat and human liver Hepatology 10 1989 437 446
47. L. Verna, J. Whysner, and G.M. Williams N-nitrosodiethylamine mechanistic data and risk assessment: bioactivation, DNA-adduct formation, mutagenicity, and tumor initiation Pharmacol. Ther. 71 1996 57 81
48. S.R. Viswanathan, and G.Q. Daley Lin28: A microRNA regulator with a macro role Cell 140 2010 445 449
49. R. Wang, L.D. Ferrell, S. Faouzi, J.J. Maher, and J.M. Bishop Activation of the Met receptor by cell attachment induces and sustains hepatocellular carcinomas in transgenic mice J. Cell Biol. 153 2001 1023 1034
50. T.C. Weglarz, J.L. Degen, and E.P. Sandgren Hepatocyte transplantation into diseased mouse liver. Kinetics of parenchymal repopulation and identification of the proliferative capacity of tetraploid and octaploid hepatocytes Am. J. Pathol. 157 2000 1963 1974
51. L.D. Wood, D.W. Parsons, S. Jones, J. Lin, T. Sjöblom, R.J. Leary, D. Shen, S.M. Boca, T. Barber, and J. Ptak The genomic landscapes of human breast and colorectal cancers Science 318 2007 1108 1113
52. T. Yamashita, M. Forgues, W. Wang, J.W. Kim, Q. Ye, H. Jia, A. Budhu, K.A. Zanetti, Y. Chen, and L.X. Qin EpCAM and alpha-fetoprotein expression defines novel prognostic subtypes of hepatocellular carcinoma Cancer Res. 68 2008 1451 1461
53. Z.F. Yang, D.W. Ho, M.N. Ng, C.K. Lau, W.C. Yu, P. Ngai, P.W. Chu, C.T. Lam, R.T. Poon, and S.T. Fan Significance of CD90+ cancer stem cells in human liver cancer Cancer Cell 13 2008 153 166
54. T. Zheng, J. Wang, H. Jiang, and L. Liu Hippo signaling in oval cells and hepatocarcinogenesis Cancer Lett. 28 2011 91 99
55. Z. Zhu, X. Hao, M. Yan, M. Yao, C. Ge, J. Gu, and J. Li Cancer stem/progenitor cells are highly enriched in CD133+CD44+ population in hepatocellular carcinoma Int. J. Cancer 126 2010 2067 2078
56. M. Zöller Tetraspanins: push and pull in suppressing and promoting metastasis Nat. Rev. Cancer 9 2009 40 55
57. A.M. Chumakov, A. Silla, E.A. Williamson, and H.P. Koeffler Modulation of DNA binding properties of CCAAT/enhancer binding protein epsilon by heterodimer formation and interactions with NFkappaB pathway Blood 109 2007 4209 4219
58. A. Gregorieff, D. Pinto, H. Begthel, O. Destrée, M. Kielman, and H. Clevers Expression pattern of Wnt signaling components in the adult intestine Gastroenterology 129 2005 626 638
59. W. Huang da, B.T. Sherman, and R.A. Lempicki Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources Nat. Protoc. 4 2009 44 57